Ophthalmic Laser Market Continues to Surge: Excimer and Femtosecond Lasers Expected to Reach US$ 2.41 Billion by 2032

The size of the world market for excimer and femtosecond ophthalmic lasers was $1.02 billion in 2021, and by the end of 2022, it is anticipated to reach US$ 1.18 billion. Furthermore, sales of excimer and femtosecond ophthalmic lasers are anticipated to grow overall at an 8.0% CAGR over the forecast period (2022 to 2032), reaching a market valuation of US$ 2.41 billion by 2032. This is due to both the rising prevalence of eye diseases around the world and the growing adoption of ophthalmic lasers.

The global excimer and femtosecond ophthalmic lasers market is expected to witness stable growth in 2016, reaching a value of US$ 666 Mn in terms of revenues. Excimer laser systems will continue to outsell femtosecond lasers. North America will remain the top market, whereas Asia Pacific (excluding China and Japan) is anticipated to create a lucrative market for excimer and femtosecond ophthalmic lasers globally.

Pronounced growth in the geriatric population and the significantly rising prevalence of diabetes will remain the key drivers fuelling the demand for excimer and femtosecond ophthalmic laser systems. Technological advancements in ophthalmic laser technology is anticipated to play a key role in catapulting their popularity and propelling their demand in the market.

With refractive and cataract surgeries growing in number, more hospitals and ophthalmology clinics are raising the demand for ophthalmic laser systems. Rising healthcare awareness and expenditure among developing economies are also expected to drive the market.

Drivers and Challenges have an Impact on Market Dynamics, which can Impact Businesses. Find more Insights in a Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-1717

High costs associated with ophthalmic laser systems may however hamper the market growth. In addition, post-LASIC complications are estimated to remain a longstanding challenge to the mass adoption of excimer and femtosecond ophthalmic laser systems.

Based on product type, excimer laser systems will continue to dominate femtosecond lasers throughout 2016. The former is predicted to contribute over 60% to the total market share, whereas the latter will witness significant Y-O-Y growth in 2016. Despite considerable adoption due to persistent technological and functionality advancements, higher costs are expected to hold a negative impact on femtosecond laser system sales.

On the basis of application, the refractive surgery segment is predicted to account for the maximum revenue share of around 70%, in 2016. It will also witness the fastest growth, compared to other segments, including cataract surgery, capsulotomy, trabeculoplasty, and diagnostics. Cataract surgery segment is projected to be the second-largest application area, witnessing substantial demand for excimer and femtosecond laser systems.

Ask Analyst for Report Customization and Explore TOC & List of Figures @ https://www.futuremarketinsights.com/ask-question/rep-gb-1717

By end-user, ophthalmology clinics segment accounted for the highest revenues of US$ 279 Mn in 2015. It is estimated to attract hefty revenues in 2016 as well, reaching US$ 291 Mn. Hospitals and ambulatory surgical centres will gain an uptick; whereas multi-chain ophthalmology hospitals are foreseen to gain prominence across the U.S., owing to soaring demand for refractive surgery.

Based on region, North America will remain the leading market and contribute over 30% revenue share to total market revenues by 2016 end. In terms of revenues, the market for excimer and femtosecond ophthalmic laser systems in N.

America is anticipated to reach a value of US$ 217 Mn in 2016, up from US$ 209 Mn in 2015. Western Europe will continue to witness significant adoption of excimer and femtosecond ophthalmic lasers, whereas Asia Pacific excluding China and Japan (APECJ) is projected to provide substantial growth opportunities.

APECJ is expected to remain a major market, owing to rapid improvisation of healthcare infrastructure in the region. China, with the highest growth rate in 2016, will represent the most lucrative market for excimer and femtosecond ophthalmic laser systems.

Key players in the global excimer and femtosecond ophthalmic laser market include Alcon Inc. (Novartis AG), Abbott Medical Optics, Inc., NIDEK CO., LTD, SCHWIND eye-tech-solutions GmbH & Co. KG, ZEISS International, Bausch & Lomb Incorporated, Ziemer Ophthalmic Systems AG, LENSAR, LLC., and iVIS Technologies.

Long-term Outlook:

Global excimer and femtosecond ophthalmic lasers market will expand at a CAGR of 5% over the forecast period, 2016-2026.

Grow your profit margin with Future Market Insights – Buy the report@ https://www.futuremarketinsights.com/checkout/1717

Key Segments Covered Product Type:

  • Excimer Laser
  • Femtosecond Laser

By Application:

  • Refractive Surgery
  • Cataract Surgery
  • Capsulotomy
  • Trabeculoplasty
  • Diagnostics

By End-User:

  • Hospital
  • Ambulatory Surgical Centers
  • Ophthalmology Clinics

Key Regions/Countries Covered:

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • Nordic Countries
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Rest of Eastern Europe
  • Asia Pacific Ex. Japan China & South Korea
    • ASEAN
    • India
    • Australia and New Zealand
    • Rest Of APEJ
  • Japan
  • China
  • South Korea
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Explore Other Reports Links From Healthcare Market:

Tip Location Devices Market Outlook[167 Pages Report] The global Tip Location Devices Market is currently valued at around US$ 38.5 Mn as of 2021, and is anticipated to progress at a CAGR of 7.0% to reach US$ 70.2 Mn by 2030.

Injectable Benzodiazepine Market Forecast: The injectable benzodiazepines market is expected to grow at a 2.7% CAGR from 2022 to 2032

Immunoassay Market Size : The global immunoassay market is expected to be worth USD 45.78 billion by 2032, growing at a CAGR of 5% from its current value of USD 29.51 billion in 2022.

About FMI:

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Leave a comment

Your email address will not be published. Required fields are marked *